Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2015

01.07.2015 | Original Article

Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population

verfasst von: Minrui Li, Shenghong Zhang, Yanqin Wu, Junzhao Ye, Xu Cao, Jie Liu, Yanhong Sun, Bihui Zhong

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Objective

Insulin resistance (IR) is a key factor involved in the development and progression of nonalcoholic fatty liver disease (NAFLD). However, the prevalence of IR in NAFLD patients and its risk factors have been rarely reported, especially in China. This prospective study was undertaken to clarify these issues in the Chinese population.

Methods

A total of 600 NAFLD patients and 300 age- and sex-matched healthy controls were recruited between January 1, 2011, and December 31, 2013. Demographic information and clinical characteristics were collected, and the presence of IR was evaluated using the homeostasis model. Uni- and multivariate analyses were conducted, and receiver operating characteristic (ROC) curves were generated to identify IR predictors.

Results

NAFLD patients had a much higher prevalence of IR than healthy controls (37.8 vs. 2.3 %, P < 0.001). The rates of elevated alanine transferase (ALT) and aspartate transferase (AST) levels were much higher in NAFLD patients with IR than those without (53.7 vs. 41.6 % and 28.6 vs. 18.2 %, respectively, P < 0.001). Uni- and multivariate analyses revealed that female sex, general obesity, abdominal obesity, and hypertension were independent predictors for IR. The area under the ROC curve for fasting plasma insulin (FPI) detecting IR was 0.93 (P < 0.001), and the optimal cutoff was 11.3 μU/ml (sensitivity = 0.86, specificity = 0.92).

Conclusion

Chinese NAFLD patients are susceptible to IR. Female sex, general and abdominal obesity, and hypertension were independent predictors for IR in NAFLD patients. FPI is an optimal predictor for IR.
Literatur
2.
Zurück zum Zitat Wright JH, Johnson MM, et al. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer. 2014;134:778–788.PubMedCentralPubMedCrossRef Wright JH, Johnson MM, et al. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma. Int J Cancer. 2014;134:778–788.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Farrell GC, Wong VW, et al. NAFLD in Asia–as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10:307–318.PubMedCrossRef Farrell GC, Wong VW, et al. NAFLD in Asia–as common and important as in the West. Nat Rev Gastroenterol Hepatol. 2013;10:307–318.PubMedCrossRef
4.
Zurück zum Zitat Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–845.PubMedCrossRef Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–845.PubMedCrossRef
5.
Zurück zum Zitat Fan JG, Saibara T, et al. What are the risk factors and settings for non-alcoholicfatty liver disease in Asia–Pacific? J Gastroenterol Hepatol. 2007;22:794–800.PubMedCrossRef Fan JG, Saibara T, et al. What are the risk factors and settings for non-alcoholicfatty liver disease in Asia–Pacific? J Gastroenterol Hepatol. 2007;22:794–800.PubMedCrossRef
6.
Zurück zum Zitat DeFronzo RA, Tobin JD, et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223.PubMed DeFronzo RA, Tobin JD, et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223.PubMed
7.
Zurück zum Zitat Bonora E, Saggiani F, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity—studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.PubMedCrossRef Bonora E, Saggiani F, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity—studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.PubMedCrossRef
8.
Zurück zum Zitat Galvin P, Ward G, et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med. 1992;9:921–928.PubMedCrossRef Galvin P, Ward G, et al. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test. Diabet Med. 1992;9:921–928.PubMedCrossRef
9.
Zurück zum Zitat Fan JG, Jia JD, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166). J Dig Dis. 2011;12:38–44.PubMedCrossRef Fan JG, Jia JD, et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163–166). J Dig Dis. 2011;12:38–44.PubMedCrossRef
10.
Zurück zum Zitat Grundy SM, Cleeman JI, et al. Diagnosis and management of the metabolic syndrome—an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752.PubMedCrossRef Grundy SM, Cleeman JI, et al. Diagnosis and management of the metabolic syndrome—an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752.PubMedCrossRef
11.
Zurück zum Zitat Greenland P, Alpert JS, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:2748–2764.PubMedCrossRef Greenland P, Alpert JS, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122:2748–2764.PubMedCrossRef
12.
Zurück zum Zitat Khanna D, Fitzgerald JD, Khanna PP et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012; 64:1431–1446. Khanna D, Fitzgerald JD, Khanna PP et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012; 64:1431–1446.
13.
Zurück zum Zitat McAuley KA, Williams SM, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460–464.PubMedCrossRef McAuley KA, Williams SM, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460–464.PubMedCrossRef
14.
Zurück zum Zitat Howard G, Bergman R, et al. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the “minimal model”. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol. 1998;8:358–369.PubMedCrossRef Howard G, Bergman R, et al. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the “minimal model”. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol. 1998;8:358–369.PubMedCrossRef
15.
Zurück zum Zitat Simarro Rueda M, Carbayo Herencia JA, Orozco JM et al. Association of insulin resistance to different anthropometric measures and cardiovascular risk factors in a non-diabetic population. Endocrinol Nutr. 2011;58:464–471. Simarro Rueda M, Carbayo Herencia JA, Orozco JM et al. Association of insulin resistance to different anthropometric measures and cardiovascular risk factors in a non-diabetic population. Endocrinol Nutr. 2011;58:464–471.
17.
Zurück zum Zitat Chen S, Chen Y, et al. Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine. 2014;46:496–504.PubMedCrossRef Chen S, Chen Y, et al. Insulin resistance and metabolic syndrome in normal-weight individuals. Endocrine. 2014;46:496–504.PubMedCrossRef
18.
Zurück zum Zitat Chiang JK, Lai NS, et al. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc Diabetol. 2011;10:93.PubMedCentralPubMedCrossRef Chiang JK, Lai NS, et al. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc Diabetol. 2011;10:93.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Bugianesi E, Gastaldelli A, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48:634–642.PubMedCrossRef Bugianesi E, Gastaldelli A, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48:634–642.PubMedCrossRef
20.
Zurück zum Zitat Kumar R, Rastogi A, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab. 2013;17:665–671.PubMedCentralPubMedCrossRef Kumar R, Rastogi A, et al. Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease? Indian J Endocrinol Metab. 2013;17:665–671.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Okita K, Iwahashi H, et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J. 2013;60:283–290.PubMedCrossRef Okita K, Iwahashi H, et al. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J. 2013;60:283–290.PubMedCrossRef
22.
Zurück zum Zitat Succurro E, Marini MA, et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity. 2008;16:1881–1886.PubMedCrossRef Succurro E, Marini MA, et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity. 2008;16:1881–1886.PubMedCrossRef
23.
Zurück zum Zitat Akande TO, Adeleye JO, et al. Insulin resistance in Nigerians with essential hypertension. Afr Health Sci. 2013;13:655–660.PubMedCentralPubMed Akande TO, Adeleye JO, et al. Insulin resistance in Nigerians with essential hypertension. Afr Health Sci. 2013;13:655–660.PubMedCentralPubMed
24.
Zurück zum Zitat Petersen KF, Dufour S, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273–18277.PubMedCentralPubMedCrossRef Petersen KF, Dufour S, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273–18277.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Jiang B, Liu Y, et al. Association of four insulin resistance genes with type 2 diabetes mellitus and hypertension in the Chinese Han population. Mol Biol Rep. 2014;41:925–933.PubMedCentralPubMedCrossRef Jiang B, Liu Y, et al. Association of four insulin resistance genes with type 2 diabetes mellitus and hypertension in the Chinese Han population. Mol Biol Rep. 2014;41:925–933.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Karrowni W, Li Y, et al. Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscl Throm Vas. 2013;33:2245–2251.CrossRef Karrowni W, Li Y, et al. Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction. Arterioscl Throm Vas. 2013;33:2245–2251.CrossRef
27.
Zurück zum Zitat Negami M, Takahashi E, et al. Prediction of homeostasis model assessment of insulin resistance in Japanese subjects. Tokai J Exp Clin Med. 2012;37:102–106.PubMed Negami M, Takahashi E, et al. Prediction of homeostasis model assessment of insulin resistance in Japanese subjects. Tokai J Exp Clin Med. 2012;37:102–106.PubMed
28.
Zurück zum Zitat Hrnciar J, Avdicova M, et al. Prevalence of metabolic syndrome, insulin resistance, and microvascular angina pectoris in 500 consecutive patients referred to coronarography. Endocr Regul. 2013;47:33–38.PubMedCrossRef Hrnciar J, Avdicova M, et al. Prevalence of metabolic syndrome, insulin resistance, and microvascular angina pectoris in 500 consecutive patients referred to coronarography. Endocr Regul. 2013;47:33–38.PubMedCrossRef
29.
Zurück zum Zitat Peng YS, Chiu YL, et al. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients. Nephrology. 2010;15:692–699.PubMedCrossRef Peng YS, Chiu YL, et al. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients. Nephrology. 2010;15:692–699.PubMedCrossRef
30.
Zurück zum Zitat Boon J, Hoy AJ, et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes. 2013;62:401–410.PubMedCentralPubMedCrossRef Boon J, Hoy AJ, et al. Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes. 2013;62:401–410.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Ying X, Qian Y, et al. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity. Acta Diabetol. 2012;49:465–472.PubMedCrossRef Ying X, Qian Y, et al. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity. Acta Diabetol. 2012;49:465–472.PubMedCrossRef
32.
Zurück zum Zitat Sung KC, Lim S, et al. Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample. Am J Hypertens. 2011;24:1041–1045.PubMedCrossRef Sung KC, Lim S, et al. Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample. Am J Hypertens. 2011;24:1041–1045.PubMedCrossRef
33.
34.
Zurück zum Zitat Magkos F, Su X, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444–14446.PubMedCentralPubMedCrossRef Magkos F, Su X, et al. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444–14446.PubMedCentralPubMedCrossRef
35.
Zurück zum Zitat Uetani E, Tabara Y, et al. Liver enzyme and adipocytokine profiles are synergistically associated with insulin resistance: the J-SHIPP Study. J Atheroscler Thromb. 2012;19:577–584.PubMedCrossRef Uetani E, Tabara Y, et al. Liver enzyme and adipocytokine profiles are synergistically associated with insulin resistance: the J-SHIPP Study. J Atheroscler Thromb. 2012;19:577–584.PubMedCrossRef
36.
Zurück zum Zitat Ghamar-Chehreh ME, Amini M, et al. Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease. Asian Pac J Trop Biomed. 2012;2:702–706.PubMedCentralPubMedCrossRef Ghamar-Chehreh ME, Amini M, et al. Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease. Asian Pac J Trop Biomed. 2012;2:702–706.PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Kawamoto R, Kohara K, et al. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012;11:117–123.PubMedCentralPubMedCrossRef Kawamoto R, Kohara K, et al. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012;11:117–123.PubMedCentralPubMedCrossRef
38.
Metadaten
Titel
Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population
verfasst von
Minrui Li
Shenghong Zhang
Yanqin Wu
Junzhao Ye
Xu Cao
Jie Liu
Yanhong Sun
Bihui Zhong
Publikationsdatum
01.07.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2015
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3564-5

Weitere Artikel der Ausgabe 7/2015

Digestive Diseases and Sciences 7/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.